New patent for BAFIERTAM’s Banner Life drug – DrugPatentWatch
Annual Drug Patent Expiration for BAFIERTAM
Bafiertam is a drug marketed by Banner Life Sciences and included in one NDA. It is available from a single supplier. There are nineteen patents protecting this drug.
This drug has eighteen patent family members in seven countries.
The generic ingredient in BAFIERTAM is monomethyl fumarate. One registered supplier for this compound. Additional details are available on the monomethyl fumarate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New Patent for BAFIERTAM’s Banner Life drug
